Showing results (441-450 of 686) with videos related to

Sort By:
Pageof 69
Cancer Research|August 1, 1990
In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patientsG J Peters, G Schwartsmann, J C Nadal, et al.
Biochemical Pharmacology|February 26, 1999
Distribution and pharmacokinetics of the prodrug daunorubicin-GA3 in nude mice bearing human ovarian cancer xenograftsP H Houba, E Boven, I H van der Meulen-Muileman, et al.
British Journal of Cancer|November 1, 1993
Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumoursM W Dercksen, K Hoekman, W W ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancersP Noordhuis, U Holwerda, C L Van der Wilt, et al.
British Journal of Haematology|October 1, 1992
Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemiaJ W Baars, J P de Boer, J Wagstaff, et al.
Journal of Clinical Pathology|April 29, 2004
A patient with a VEGF and endostatin producing gastrointestinal autonomic nerve tumourA H G Hansma, Y van Hensbergen, B C Kuenen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent culturesP E Pizao, G J Peters, J Van Ark-Otte, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1988
Morphometric study of myocardial changes during doxorubicin-induced cardiomyopathy in miceW J van der Vijgh, D van Velzen, J S van der Poort, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 6, 2001
Evaluation of perianal sepsis: comparison of anal endosonography and magnetic resonance imagingA G Maier, M A Funovics, S H Kreuzer, et al.
BMC Medical Ethics|May 5, 2026
Implicit ethical choices in ultra-rare therapy development: researchers' perspectives on patient selection and communication, therapy value, and accessibilityMariia V Maksimova, Rosan L Lechner, Felicia V Y L Lee-Kong, et al.
Pageof 69